NeoGenomics Correlations
NEO Stock | USD 9.82 0.30 3.15% |
The current 90-days correlation between NeoGenomics and Neogen is 0.07 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoGenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoGenomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
NeoGenomics Correlation With Market
Weak diversification
The correlation between NeoGenomics and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NeoGenomics and DJI in the same portfolio, assuming nothing else is changed.
NeoGenomics |
Moving together with NeoGenomics Stock
0.91 | VTYX | Ventyx Biosciences | PairCorr |
0.62 | ELEV | Elevation Oncology | PairCorr |
0.65 | ELUT | Elutia Inc | PairCorr |
0.86 | ELVN | Enliven Therapeutics | PairCorr |
0.78 | ENVB | Enveric Biosciences | PairCorr |
0.75 | ESPR | Esperion Therapeutics | PairCorr |
0.83 | EYEN | Eyenovia Earnings Call Tomorrow | PairCorr |
0.77 | BIO | Bio Rad Laboratories | PairCorr |
0.65 | EVO | Evotec SE ADR | PairCorr |
0.81 | XFOR | X4 Pharmaceuticals Earnings Call This Week | PairCorr |
0.92 | KOD | Kodiak Sciences | PairCorr |
0.89 | KZR | Kezar Life Sciences | PairCorr |
0.81 | RDY | Dr Reddys Laboratories | PairCorr |
0.92 | GNPX | Genprex | PairCorr |
Moving against NeoGenomics Stock
0.89 | VRNA | Verona Pharma PLC Downward Rally | PairCorr |
0.8 | VALN | Valneva SE ADR Earnings Call This Week | PairCorr |
0.57 | EOLS | Evolus Inc | PairCorr |
0.55 | VIGL | Vigil Neuroscience | PairCorr |
0.47 | ETON | Eton Pharmaceuticals | PairCorr |
0.89 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.75 | IVA | Inventiva Sa | PairCorr |
0.69 | LLY | Eli Lilly | PairCorr |
0.59 | PLX | Protalix Biotherapeutics | PairCorr |
0.55 | FENC | Fennec Pharmaceuticals | PairCorr |
0.53 | PBH | Prestige Brand Holdings | PairCorr |
0.49 | BMY | Bristol Myers Squibb | PairCorr |
0.89 | GILD | Gilead Sciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NeoGenomics Stock performing well and NeoGenomics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NeoGenomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NTRA | 2.11 | (0.06) | 0.00 | (0.16) | 0.00 | 4.36 | 13.77 | |||
QGEN | 1.20 | (0.11) | 0.00 | (0.50) | 0.00 | 2.95 | 7.05 | |||
NEOG | 2.07 | (0.45) | 0.00 | (1.00) | 0.00 | 3.92 | 12.07 | |||
GH | 3.30 | 0.55 | 0.11 | 0.18 | 3.53 | 6.28 | 32.66 | |||
CDNA | 3.01 | (0.12) | 0.00 | (0.17) | 0.00 | 5.88 | 19.59 | |||
MYGN | 2.63 | (0.48) | 0.00 | (0.80) | 0.00 | 4.14 | 26.72 | |||
CSTL | 2.41 | (0.64) | 0.00 | (3.51) | 0.00 | 4.51 | 23.81 | |||
SYNH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MTD | 1.21 | 0.06 | 0.00 | (0.04) | 0.00 | 2.34 | 8.60 |
NeoGenomics Corporate Management
Facmg MBA | Pres Officer | Profile | |
Nathan MD | Vice Services | Profile | |
George Cardoza | Pres Operations | Profile | |
Kareem Saad | Head Transformation | Profile | |
Gary Passman | Chief Officer | Profile |